Myeloma proteins as tumor-specific antigens
- PMID: 48299
Item in Clipboard
Myeloma proteins as tumor-specific antigens
Transplant Proc.
1975 Jun.
No abstract available
Similar articles
-
A monoclonal antiidiotypic antibody to MOPC 315 IgA inhibits the growth of MOPC 315 myeloma cells in vitro.J Immunol. 1981 Jan;126(1):113-7. J Immunol. 1981. PMID: 7451962
-
Major histocompatibility complex control of the idiotypic network in the MOPC 173 system.Eur J Immunol. 1981 Oct;11(10):769-76. doi: 10.1002/eji.1830111007. Eur J Immunol. 1981. PMID: 6171432 No abstract available.
-
Enhancement of immunogenicity of a BALB-c myeloma protein in BALB-c mice.J Immunol. 1974 Sep;113(3):791-7. J Immunol. 1974. PMID: 4213082 No abstract available.
-
The developmental history of the neoplastic plasma cell in mice: a brief review of recent developments.Semin Hematol. 1973 Jan;10(1):19-32. Semin Hematol. 1973. PMID: 4569738 Review. No abstract available.
-
Genetic control of antibody responses to myeloma proteins of mice.Contemp Top Immunobiol. 1974;3:117-39. doi: 10.1007/978-1-4684-3045-5_5. Contemp Top Immunobiol. 1974. PMID: 4133994 Review. No abstract available.
Cited by
-
Active immunotherapy: current state of the art in vaccine approaches for NHL.Curr Oncol Rep. 2012 Oct;14(5):433-40. doi: 10.1007/s11912-012-0255-7. Curr Oncol Rep. 2012. PMID: 22843515 Free PMC article. Review.
-
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.Cancer Res. 2008 Jul 1;68(13):5439-49. doi: 10.1158/0008-5472.CAN-07-6621. Cancer Res. 2008. PMID: 18593947 Free PMC article.
-
Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study.Cancer Immunol Immunother. 2015 Aug;64(8):1021-32. doi: 10.1007/s00262-015-1703-7. Epub 2015 May 16. Cancer Immunol Immunother. 2015. PMID: 25982371 Free PMC article. Clinical Trial.
-
In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.Immunology. 1984 Feb;51(2):377-85. Immunology. 1984. PMID: 6607213 Free PMC article.
-
Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins.Front Oncol. 2012 Nov 9;2:159. doi: 10.3389/fonc.2012.00159. eCollection 2012. Front Oncol. 2012. PMID: 23162790 Free PMC article.